Does ILOPROST Cause Product prescribing issue? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Product prescribing issue have been filed in association with ILOPROST (AURLUMYN). This represents 0.5% of all adverse event reports for ILOPROST.
24
Reports of Product prescribing issue with ILOPROST
0.5%
of all ILOPROST reports
8
Deaths
13
Hospitalizations
How Dangerous Is Product prescribing issue From ILOPROST?
Of the 24 reports, 8 (33.3%) resulted in death, 13 (54.2%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ILOPROST. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does ILOPROST Cause?
Death (1,369)
Dyspnoea (662)
Headache (353)
Cough (284)
Pulmonary arterial hypertension (284)
Hospitalisation (281)
Fatigue (280)
Dizziness (225)
Pneumonia (224)
Pulmonary hypertension (216)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
Which ILOPROST Alternatives Have Lower Product prescribing issue Risk?
ILOPROST vs IMATINIB
ILOPROST vs IMBRUVICA
ILOPROST vs IMDEVIMAB
ILOPROST vs IMEGLIMIN
ILOPROST vs IMETELSTAT